FDA Adverse Event Malfunction Summary report: N

UNICEL® DXL 600 ACCESS® IMMUNOASSAY SYSTEM

MDR report key: 2194224 · Received August 6, 2011

Report

Report Number
2122870-2011-02775
Event Type
Malfunction
Date Received
August 6, 2011
Date of Event
July 7, 2011
Report Date
July 7, 2011
Manufacturer
BECKMAN COULTER INC.
Product Code
JJE
PMA / PMN Number
K023764
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

SAMPLE WAS LITHIUM HEPARIN PLASMA THAT WAS ORIGINALLY CENTRIFUGED FOR 7 MINUTES AT 3850RPM. PER CUSTOMER, THE SAMPLE LOOKED CLEAR AND THERE WERE NO NOTED ISSUES WITH THE SAMPLE QUALITY. QC IS PERFORMED ONCE DAILY AND WAS WITHIN THE CUSTOMER'S ESTABLISHED RANGES DURING THIS EVENT. THE CUSTOMER PERFORMED A SYSTEM CHECK AND A 10 POINT PRECISION RUN AFTER THE ERRONEOUS RESULTS ABOVE AND BOTH MET SPECIFICATIONS. THE CUSTOMER DECLINED SERVICE AS ONLY ONE PATIENT SAMPLE WAS IN QUESTION.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC. (BEC) REGARDING CREATINE KINASE-MB (CKMB) RESULTS GENERATED BY THE UNICEL DXL 600 ACCESS IMMUNOASSAY SYSTEM FOR ONE PATIENT'S SAMPLE. THE PATIENT'S INITIAL CKMB RESULT WAS 67.1NG/ML (TOTAL CK RESULT WAS 68NG/ML AND THE PATIENT'S PREVIOUS TOTAL CK RESULT WAS 63NG/ML.) THE CUSTOMER QUESTIONED THE RESULT AND DID NOT REPORT IT OUTSIDE OF THE LABORATORY. THE SAMPLE WAS POURED OFF AND REPEAT TESTING WAS PERFORMED. THE REPEAT CKMB RESULT WAS 68.8NG/ML AND TOTAL CK RESULT WAS 55NG/ML. THE SAMPLE WAS THEN CENTRIFUGED FOR 3 MINUTES AND THE REPEAT CKMB RESULT WAS 4.7NG/ML ON THIS INSTRUMENT AND 3.7NG/ML ON AN ALTERNATE INSTRUMENT. NO REPORTS OF PATIENT INJURY REQUIRING MEDICAL INTERVENTION OR CHANGE TO PATIENT TREATMENT HAVE BEEN ATTRIBUTED OR CONNECTED TO THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL® DXL 600 ACCESS® IMMUNOASSAY SYSTEM DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER JJE BECKMAN COULTER INC. DXI 600 NA

Patients

Seq Age Sex Outcome Treatment
1